InsidersTradesSigma
Browse the full record of transactions filed by Cohen Yuval, Chief Executive Officer. Director active across 1 companies, notably Corbus Pharmaceuticals Holdings, Inc.. Aggregated, 2 reports have been logged. Total volume traded: €5k. The latest transaction was disclosed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Yuval Cohen is the CEO of Corbus Pharmaceuticals Holdings, Inc. He oversees the company's overall strategy and operations. With expertise in the biopharmaceutical sector, he is committed to leading innovation and developing treatments that meet patient needs. His leadership is crucial for Corbus's success.